JBJonathan Bath

Jonathan Bath

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jonathan Bath has a total of 455 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Outcomes from the real-world multicenter laser in situ fenestrated endovascular repair (LIFE) registry for complex thoracoabdominal and pararenovisceral aortic pathology

    by Jonathan Bath, Fanny Alie-Cusson, Sukgu M. Han, Gregory A. Magee, Andrew Barleben, Robert Allen, Mark Fugate, Frank R. Arko, Jordan R. Stern, Kenneth Tran, et al.

  • Open Access

    How I do it: Zone 0 arch treatment with laser in situ fenestrated endograft repair

    by Uttara Nag, Nicole Hatala, David Sniatkewicz, Todd R. Vogel, Steven Cheung, Jonathan Bath

  • Mid-term outcomes of covered and bare metal stents for femoropopliteal atherosclerotic disease

    by Margaret Kurop, Andrew Bedford, Sara Beudoin, Jennifer Huffman, Chase Schlesselman, Todd R. Vogel, Steven Cheung, Jonathan Bath

    Objective: Endovascular modality used in peripheral vascular intervention (PVI) varies widely. Long-term outcomes are poorly studied between covered stents (CS) and bare metal stents (BMS) for the SFA. Methods: Patients (2017–2021) undergoing CS and BMS to the SFA were identified at an academic institution. Comparative statistics and Kaplan–Meier analysis were used to evaluate outcomes by group. Results: One hundred and nineteen patients undergoing stenting were included with 60 patients undergoing CS (50%) and BMS in 59 (50%). There were no differences in sex ( p = 0.5), preoperative ABI ( p = 0.2) or indication for surgery between groups ( p = 0.8). CS patients had undergone more prior SFA interventions ( p = 0.03) and were younger (62 vs. 66 years; p = 0.04). Regarding anatomic and operative characteristics, CS patients had more TASC C/D lesions (69 vs. 47%; p = 0.006) less severe calcification (8 vs.17%; p = 0.0006) and more often underwent angioplasty and stenting (90 vs 51%; p < 0.0001) and less often angioplasty, DCB and stenting (5 vs. 43%; p < 0.0001). CS patients had larger SFA (5.7 vs 4; p < .0001), longer lesions (119 vs. 89 mm; p = 0.0008), higher popliteal runoff score (8.3 vs. 6.4; p = 0.02), longer surgery (140 vs. 118 min; p = 0.03), less fluoroscopy time (21 vs. 26 min; p = 0.03), larger SFA stent (6.2 vs. 5.6 mm; p < 0.0001), and longer stented length (260 vs. 171 mm; p < 0.0001). There were no differences in concomitant iliac/tibial treatment between groups ( p = 0.3). Regarding outcomes, there were no differences in amputation (CS 10 vs. BMS 10.2%; p = 1) but overall mortality was lower in CS patients (8 vs 22%; p = 0.04) as was acute limb ischemia (17 vs. 34%; p = 0.03). CS patients underwent fewer endovascular ( p = 0.03) and open reinterventions ( p = 0.005) but a shorter time to first endovascular reintervention (5.6 vs. 17.8 months; p = 0.0002) on unadjusted analysis. Kaplan-Meier estimated survival at 48 months was 83% for CS and 75% for BMS ( p = 0.28). At 36 months, primary patency was 35% for CS vs. 41% for BMS ( p = 0.09), primary-assisted patency was 57% for CS vs. 68% for BMS ( p = 0.04) and secondary patency for CS was 61% vs. 61% for BMS ( p = 0.99). Conclusions: In this series, CS was associated with lower reintervention rates than BMS despite higher TASC classification, longer lesions, and higher popliteal runoff scores. CS was more often used to salvage previous SFA intervention. At 3 years, however, patency was similar between groups. These data suggest some advantages for CS over BMS in endovascular salvage of failed SFA intervention and potentially a preferred modality for more complex SFA lesions than BMS.

  • Outcomes of unibody endoprosthesis for treatment of aortic aneurysmal pathology and aortoiliac occlusive disease

    by Benjamin Liu, Caroline Chung, Iman Mohammed, Chase Schlesselman, Todd R. Vogel, Steven Cheung, Jonathan Bath

    Objective: Unibody Endoprosthesis (UBE) is a newer treatment modality for abdominal aortic pathology (AAP) and has increasingly been utilized for aortoiliac occlusive disease (AIOD). We report outcomes of patients undergoing UBE for AAP and AIOD. Methods: Patients (2016–2021) undergoing UBE were identified retrospectively at an academic institution. AAP included aneurysm/pseudoaneurysm/PAU. Chi-square and Kaplan-Meier analysis were used to evaluate outcomes by group. Results: 90 patients undergoing UBE were included with 39 patients undergoing AAP (43%) and AIOD treatment in 51 (57%). AAP patients were older (72.9 vs 62.5 years; p = .01), with a lower prevalence of female patients treated than AIOD (36% vs 57%; p = .04), diabetes (23% vs 45%; p = .03) and current smokers (46% vs 69%; p = .03). There were significant differences in arterial diameters with AAP patients exhibiting larger minimum aortic diameter (19 mm vs 15 mm; p < .0001), iliac (12.5 mm vs 9.8 mm; p < .0001), femoral (9 mm vs 6.9 mm; p < .0001), SFA (6.8 mm vs 5.2 mm; p < .0001) and profunda femoris (6 mm vs 4.9 mm; p = .002). Shorter surgery duration was seen with AAP than AIOD patients (135 min vs 194 min; p = .001). There were six major amputations in the overall cohort with two BKA and four AKA. There were no significant differences in unadjusted 30-day outcomes or mid-term outcomes between groups at a mean follow-up period of 20 months. Reinterventions over the follow-up period occurred in 9 limbs (5%) in the overall cohort with no significant associations between demographic or anatomic variables identified. Subgroup analysis of the whole cohort by sex revealed that female patients exhibited smaller minimum aortic diameter (14.9 mm vs 18.6 mm; p < .0001), common iliac (9.3 mm vs 12.5 mm; p < .0001), femoral (6.9 mm vs 8.7; p < .0001), SFA (5.2 mm vs 6.6 mm; p < .0001) and profunda femoris (4.9 mm vs 5.9 mm; p = .0006). Logistic regression analysis revealed an independent association between minimum aortic diameter (OR 1.61; 95% CI 1.0–2.4) and surgery length (OR 1.02; 95% CI 1–1.03) and overall mortality. Kaplan-Meier estimated survival at 36 months was 94% for AIOD and 84% for AAP ( p = .23). At 36 months, primary patency was 78% for AIOD versus 100% for AAP ( p = .002), primary-assisted patency was 94% for AIOD versus 100% for AAP ( p = .12) and secondary patency for AIOD was 82% versus 100% for AAP ( p = .008). Conclusions: UBE can be safely and effectively used for treating aortic aneurysmal pathology as well as aortoiliac occlusive disease in selected patients. Despite the differing pathologies, outcomes are similar with a low reintervention rate and excellent mid-term patency of the intervention. Interestingly, an independent association between mortality and small minimum aortic diameter was seen, further reinforcing AIOD as a marker for overall mortality when compared with aneurysm patients.

  • Open Access

    How to curate high-quality vascular images and videos for publication

    by Jonathan Bath, Bwaar Omer, Anne Marker, Bernardo C. Mendes

  • Multi-institutional study of outcomes from portal vein reconstruction during pancreatic cancer surgery

    by Suma Gondi, Madeleine McSpadden, Chase Schlesselman, Michael Williams, Kristen Dougherty, Kyla M. Bennett, Leah Gober, Jonathan Bath

  • Open Access

    Transatlantic Delphi Consensus on the Common Iliac Artery Sealing Zone in Endovascular Aorto-Iliac Aneurysm Repair (the DECIDE Study)

    by Maria-Annette Kooijman, Mario D’ORia, Luca Bertoglio, Isabelle Van Herzeele, Ross Milner, Jean-Paul P.M. de Vries, Richte C.L. Schuurmann, Gautam Agarwal, Michele Antonello, Frederico Bastos Goncalves, et al.

    Objective: Knowledge of hostile factors and their influence on long-term seal in the iliac landing zone is limited. Currently endorsed clinical practice guidelines lack structural evidence on how the iliac landing zone should be assessed in the pre-, intra-, and postoperative phases. The goal of this study was to obtain an international, expert-based consensus on the definition of a hostile iliac landing zone, on how to size and plan stent-grafts to optimize sustainable distal seal, and on the postprocedural follow-up protocol. Methods: Delphi consensus methodology was used, involving a panel of international vascular surgeons experienced in endovascular aneurysm repair (EVAR). The first round consisted of open-ended and multiple-choice questions to explore current practices, with subsequent rounds refining statements through a 4-point Likert scale. Consensus was defined as >75% agreement or disagreement, and the analysis included stability testing and strength of consensus. Results: The study engaged 77 international vascular surgeons, reflecting diverse geographic locations and hospital affiliations. Consensus was achieved on critical preoperative planning elements for EVAR, including a clear definition for a hostile iliac landing zone. The importance of computed tomography angiography for postoperative follow-up imaging was emphasized, including evaluating distal seal length and recommending specific timing for follow-up computed tomography scans and intervention strategies for diminishing iliac seal. Conclusions: This international expert-based Delphi consensus establishes a comprehensive set of consensus-driven recommendations focused on the definition and management of hostile iliac landing zones in EVAR. The key recommendation of this study is the definition of a hostile iliac landing zone as short (24 mm), or conical (>10% diameter difference along the landing zone). Although consensus was achieved on several critical aspects, the study also reveals ongoing debates and considerations that warrant further exploration, including how to tackle diminishing seal without a type IB endoleak. Clinical Impact: This Delphi consensus introduces a standardized definition of a hostile iliac landing zone as short (24 mm), or conical (>10% diameter difference), clinicians now have a clearer framework for assessing complex anatomies. This study provides a comprehensive set of consensus-driven recommendations focused on the definition and management of hostile iliac landing zones in EVAR which gives guidance where current guidelines lack specificity, particularly for distal iliac sealing. The study also reveals ongoing debates and considerations that warrant further exploration, including how to tackle diminishing seal without a type IB endoleak.


  • Retrograde open mesenteric stenting and outcomes for acute mesenteric ischemia

    by Maraya Camazine, Chase Schesselman, Iris Zachary, Jonathan Bath, Todd R Vogel

    Objectives: Data regarding retrograde open mesenteric stenting (ROMS) for urgent mesenteric ischemia is limited to small single center and case series, with variable utilization across patient populations and ill-defined outcomes. We aimed to evaluate characteristics and outcomes of patients with acute mesenteric ischemia requiring urgent surgical intervention. Methods: Retrospective cohort study of patients with mesenteric ischemia requiring urgent surgical intervention from 2018 to 2020 was queried from the National Inpatient Sample (NIS) database. Study groups were defined as those requiring an open bypass (BYPASS), an open superior mesenteric artery embolectomy (OPEN), or ROMS. Descriptive statistics were used to report variables. Comparisons were mad using t test, chi-squares tests, and multivariate regression reported as odds ratio (OR), 95% confidence interval (CI) where appropriate. Results: 898 patients with mesenteric ischemia requiring urgent surgical intervention were included: Bypass: 284, OPEN: 363, ROMS: 251. There was no difference in gender or race between groups. Patients requiring ROMS were more likely to be older 70.2 + 11.3versus Bypass 66.81 + 11.6 and OPEN 67.17 + 14.5, p = 0.0035. ROMS patients had the highest Charlson Comorbidity Index (CCI) 2.9 versus 2.5 Bypass and 2.6 OPEN, p = 0.0292 with the most frequent comorbidities: Diabetes 37% ( p = 0.01), renal disease 24.3% ( p = 0.5), and previous preoperative myocardial infarction 9.2%, p = 0.05; however, the lowest mortality rate was seen within this Group 15.9% versus bypass 19.7%, OPEN 34.5%, p < 0.0001. Patients requiring bypass were more likely to have chronic pulmonary disease 34.5% versus OPEN 24.2% and ROMS 31.5%, p = 0.013, peripheral vascular disease (PVD) 38% versus OPEN 16%, and ROMS 29.9%, p < 0.0001. On multivariate regression, ROMS was associated with 50% decreased incidence of mortality (OR 0.45, 95% CI 0.27–0.75). Open SMA embolectomy was associated with nearly 2x mortality rate compared to bypass procedures OR 2.0, 95% CI 1.3–3.0, p < 0.001. Previous MI was also associated with nearly 2x incidence of mortality (OR 1.9, 95% CI 1.01–3.6), while pre-existing PVD conferred a protective effect (OR 0.56, 95% CI 0.36–0.89). Higher CCI and age were associated with slightly increased risk for mortality OR 1.2 and 1.03, p < 0.05 for both. Conclusions: In patients with acute mesenteric ischemia, ROMS demonstrated a significant mortality benefit compared to traditional open procedures. Advanced age, history of MI, and open SMA embolectomy were associated with increased mortality. Little data exists regarding ROMS in a real-world population evaluating ROMS, which is a newer technique. These data suggest that ROMS may be a superior alternative to restore mesenteric flow in the acute setting and further prospective studies evaluating ROMS to other procedural types in urgent and elective settings are needed.


  • Intraluminal crossing of infrainguinal SFA chronic total occlusions may offer patency superiority compared to subintimal crossing

    by Maraya Camazine, Jack Coorts, Terrell Christian, Chase Schlesselman, Robin L. Kruse, Jonathan Bath, Todd R. Vogel

    Objectives: Patency for chronic total occlusions (CTO) of the superficial femoral artery (SFA) after endovascular interventions traditionally demonstrate a low 1-year patency ranging from 40%–60%. The optical coherence tomography (OCT) catheter (Avinger Inc., Redwood City, CA) uses light-based technology imaging to cross Trans-Atlantic Inter-Society Consensus D (TASC D) lesions intraluminally with direct intra-arterial visualization. Insufficient data exist evaluating intraluminal crossing with OCT imaging compared with traditional subintimal techniques. We evaluated outcomes for TASC D lesions crossed intraluminally. Methods: A retrospective analysis of patients with SFA TASC D lesions crossed intra-arterially with the OCT catheter imaging. Descriptive statistics evaluated patient characteristics which included patient demographics, Rutherford scores, ABIs, CTA information, lesion categorization, as well as runoff score. Patency at baseline, 30-day, 6-month, and 1-year outcomes were compared using t-tests. Cumulative patency rates were evaluated using Kaplan–Meier analysis. Results: 101 patients underwent elective intervention for SFA TASC D lesions with the OCT catheter. The crossing rate was 78.2%, mean lesion length was 16.2 cm, and runoff at the tibial level was 2.2 patent vessels. Mean age and BMI were 64 years and 29 kg/m 2 , respectively. Patient characteristics are male (57%); Caucasian (90%); ever smoking (85%); hypertension (82%), hyperlipidemia (70%), and diabetes (46%). Pre-operative computed tomography demonstrated SFA lesions were predominantly eccentric (91%) with mild to moderate calcification (90%). All underwent PTA, 87% were stented (mean stent length: 186.1 mm), mean crossing time was 13.4 min. Pre-operative, 30-day, 6-month, and 1-year post-operative mean Rutherford–Becker scores were 4, 1, 1, and 1, respectively ( p < 0.0001). Mean pre-operative ABI was 0.49, compared to 0.84 at 30 days, 0.64 at 6 months, and 0.67 at 1 year ( p < .0001). Duplex demonstrated 6- and 12-month primary patency of 89% and 75%; primary-assisted patency was 94% and 84%. Conclusions: The OCT imaging catheter successfully crossed long chronic total occlusions of the SFA using direct intra-arterial imaging. Compared to subintimal techniques, patients had high 1-year primary patency and prolonged symptom improvement with intraluminal crossing. These data suggest that intraluminal crossing of TASC D lesions may be superior to traditional subintimal crossing techniques.